KSCM
MRK icon

Key Square Capital Management’s Merck MRK Stock Holding History

Key Square Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-694,510
Closed -$42.5M – 28
2017
Q2 		$42.5M Buy
+694,510
New +$42.3M 6.33% 7

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Key Square Capital Management's MRK Position: Q3 2017 in Review

Key Square Capital Management sold out of Merck (MRK) in Q3 2017, closing a stake of 694,510 shares — an estimated $42.5M sold.

Key Square Capital Management first reported a position in MRK in Q2 2017 and held it in 1 quarter. The position peaked at $42.5M in Q2 2017. 1,923 funds tracked by Wall St. Rank hold MRK as of Q3 2017.

  • Key Square Capital Management reported no remaining Merck position as of Q3 2017 after selling out during the quarter.
  • Key Square Capital Management sold 694,510 Merck shares in Q3 2017, an estimated $42.5M.
  • Key Square Capital Management first reported a position in Merck in Q2 2017 and held it in 1 quarter.
  • Key Square Capital Management's Merck position peaked at $42.5M in Q2 2017.
  • 1,923 funds tracked by Wall St. Rank held Merck as of Q3 2017.

Based on Key Square Capital Management's 13F filing for Q3 2017, filed 7 Nov 2017.